Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Follow-up Protocol for Participants Treated With Gene Modified T Cells

NCT06798298 is registered in ClinicalTrials.gov with Regeneron Pharmaceuticals as lead sponsor.

NCT NCT06798298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06798298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Follow-up Protocol for Participants Treated With Gene Modified T Cells
Lead sponsor
Regeneron Pharmaceuticals
Phase
Observational
Overall status
Recruiting
Start date
November 10, 2025
Completion date
June 17, 2040
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long term safety following gm t cell therapy